What it sells
Bio AI for everyday health diagnostics
Business model breakdown
Buyer: who owns the budget?
UnverifiedIndividual consumers buying at pharmacies and online.
Trigger: what makes them buy now?
Anxiety after intercourse and need for self testing at home (meta description).
Workflow: what inputs become what output?
Sampling, then amplified quantitative reading (Amp.Vision), then personalised monitoring insights.
Economics: what it saves and how it charges
UnverifiedPer-kit consumer product sales via pharmacy chains and own brand; MFDS approval for MSK kit in 2026.05.
Distribution: how it reaches customers
Sells through its everyday-diagnostics brand Winti (winti.kr) and offline pharmacy chains; site newsroom reports Winti listed at Megatown Pharmacy branches nationwide (2026-08-31).
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-06-30 | Seed | — | Bluepoint Partners | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-13.